Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Jump to section
Related Articles
Cited By...
- Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?
- Positive Predictive Value of Neck Imaging Reporting and Data System Categories 3 and 4 Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
- Negative Predictive Value of NI-RADS Category 2 in the First Posttreatment FDG-PET/CT in Head and Neck Squamous Cell Carcinoma
- Surveillance Imaging in HPV-related Oropharyngeal Cancer
- Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma
- Evaluating the Potential Role of PET/CT in the Posttreatment Surveillance of Head and Neck Cancer
- Guideline Familiarity Predicts Variation in Self-Reported Use of Routine Surveillance PET/CT by Physicians Who Treat Head and Neck Cancer